Luqi Zhao, M.D., University of Houston College of Pharmacy postdoctoral research scientist in the Department of Pharmacological & Pharmaceutical Sciences (PPS), is working to uncover a new mechanism in left ventricular non-compaction. She has received a two-year, $163,864 postdoctoral fellowship from the American Heart Association to investigate the “Pathogenesis of acquired left ventricular non-compaction,” a rare and severe cardiomyopathy.

Wei Wang, Ph.D., research associate professor, has joined a $3.2 million effort to develop a promising new treatment for triple-negative breast cancer (TNBC), one of the most aggressive and difficult-to-treat forms of the disease. The team is developing a new kind of drug designed to attack MDM2, a cancer-driving protein often found at high levels in TNBC and has been linked to faster tumor growth and worse outcomes for patients.

The American Academy of Microbiology, a leadership group within the American Society for Microbiology (ASM), has elected UHCOP Professor Vincent H. Tam, Pharm.D., FIDSA, FIDP, BCIDP, to the Fellowship Class of 2026.